Status:
UNKNOWN
Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19
Lead Sponsor:
Olive View-UCLA Education & Research Institute
Conditions:
Lung Injury
ARDS
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to define the ultrasound profile of patients with COVID-19, and document the progression of these ultrasound findings to develop prognostication and clinical decision instruments that...
Detailed Description
A. SPECIFIC AIMS 1. To define the lung ultrasound profile of patients admitted with COVID-19 pneumonia, hypoxia, or hypoxemic respiratory failure. 2. To document the progression of POCUS findings in ...
Eligibility Criteria
Inclusion
- Patients with confirmed COVID-19 pneumonia as the primary diagnosis, or COVID- associated acute hypoxemic respiratory failure or hypoxia (minimum O2 requirement 3L), that are being admitted from the emergency department, who either have waiver of consent, give verbal consent to participate, or have next of kin give consent for participation.
Exclusion
- age \< 18 years old, pregnant patients, or patients that verbally refuse participation
Key Trial Info
Start Date :
November 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05228717
Start Date
November 10 2020
End Date
June 1 2022
Last Update
April 29 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA-Ronald Reagan
Los Angeles, California, United States, 90095
2
Olive View-UCLA
Sylmar, California, United States, 91342
3
SUNY Downstate
New York, New York, United States, 11203
4
Temple University
Philadelphia, Pennsylvania, United States, 19140